Dear readers! We are pleased to present you the sixth issue of the LOGISTICS magazine in 2025, which contains a lot of relevant materials. In the latest issue, our permanent partner COMITAS company presents an innovative solution dictated by the shortage of warehouse space and difficulties with personnel selection – the high-rise automated self-supporting "COMITAS Warehouse".
Dear readers! The first half of the year is approaching, which means that on the pages of the fifth issue of the magazine you will find a lot of useful analytical materials on the markets of warehouse real estate, cargo transportation, etc. Our authors Yu.V. Klimenko, M.G. Grigoryan, R.N.
Dear readers! We present to your attention the fourth issue of the LOGISTICS journal. By tradition, in the April issue we summarize the results of TransRussia | SkladTech 2025. This year, the exhibition attracted a record number of exhibitors and over 30,000 visitors. Under the heading "non-economic activity", we are posting an interesting article by A.V. Efimov on the prospects for the development of non-primary non-energy exports from Russia to Vietnam.
CV PROTEK (Protek Group) has been ranked first among the largest distributors for the 1-2 quarters of 2018, prepared by DSM Group marketing agency.
The company’s market share, according to the DSM data, was equal to 16.5% (in value terms- 109.3 billion rubles). Katren with market share of 16.5% is at the second place. While shares of two distributors in percentage terms are equal, Katren’s share in value termsis equal to 108.9 billion rubles. Puls (14.1%) is at the third position of the rating.
Distributors rating for the 1HY 2018
Rank |
Distributor |
Amount, billion rubles |
Dynamics |
Share |
1 |
Protek |
109.3 |
-5.2% |
16.5% |
2 |
Katren |
108.9 |
-0.4% |
16.5% |
3 |
Puls |
93.4 |
18.0% |
14.1% |
4 |
SIA |
29.7 |
-10.4% |
4.5% |
5 |
Pharmcomplect |
29.5 |
2.0% |
4.5% |
6 |
R-Pharm |
29.1 |
-15.4% |
4.4% |
7 |
Grand Capital |
26.5 |
46.0% |
4.0% |
8 |
BSS |
25.1 |
19.8% |
3.8% |
9 |
Profit-med |
21.2 |
47.4% |
3.2% |
10 |
Avesta Pharmaceuticals |
11.6 |
46.0% |
1.8% |